180 related articles for article (PubMed ID: 9351567)
1. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases.
Lin O; Frizzera G
Am J Surg Pathol; 1997 Nov; 21(11):1295-306. PubMed ID: 9351567
[TBL] [Abstract][Full Text] [Related]
2. Follicular dendritic cell sarcoma complicated by hyaline-vascular type Castleman's disease in a schizophrenic patient.
Katano H; Kaneko K; Shimizu S; Saito T; Irié T; Mori S
Pathol Int; 1997 Oct; 47(10):703-6. PubMed ID: 9361105
[TBL] [Abstract][Full Text] [Related]
3. Cytopathology of follicular dendritic cell tumors.
Wright CA; Nayler SJ; Leiman G
Diagn Cytopathol; 1997 Aug; 17(2):138-42. PubMed ID: 9258622
[TBL] [Abstract][Full Text] [Related]
4. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease.
Chan JK; Tsang WY; Ng CS
Am J Surg Pathol; 1994 May; 18(5):517-25. PubMed ID: 8172326
[TBL] [Abstract][Full Text] [Related]
5. Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature.
Pina-Oviedo S; Miranda RN; Lin P; Manning JT; Medeiros LJ
Hum Pathol; 2017 Oct; 68():136-146. PubMed ID: 28873356
[TBL] [Abstract][Full Text] [Related]
6. Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies.
Chan AC; Chan KW; Chan JK; Au WY; Ho WK; Ng WM
Histopathology; 2001 Jun; 38(6):510-8. PubMed ID: 11422494
[TBL] [Abstract][Full Text] [Related]
7. Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis.
Danon AD; Krishnan J; Frizzera G
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):369-82. PubMed ID: 8116226
[TBL] [Abstract][Full Text] [Related]
8. Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants.
Nguyen DT; Diamond LW; Hansmann ML; Alavaikko MJ; Schröder H; Fellbaum C; Fischer R
Histopathology; 1994 May; 24(5):437-43. PubMed ID: 8088715
[TBL] [Abstract][Full Text] [Related]
9. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
[TBL] [Abstract][Full Text] [Related]
10. Cytologic demonstration of "dysplastic" follicular dendritic cells in a case of hyaline-vascular Castleman's disease.
Taylor GB; Smeeton IW
Diagn Cytopathol; 2000 Apr; 22(4):230-4. PubMed ID: 10787143
[TBL] [Abstract][Full Text] [Related]
11. Proliferative lesions in Castleman's disease.
Desai S
Am J Surg Pathol; 1999 Jan; 23(1):134. PubMed ID: 9888716
[No Abstract] [Full Text] [Related]
12. Angiomyoid proliferative lesion: an unusual stroma-rich variant of Castleman's disease of hyaline-vascular type.
Izumi M; Mochizuki M; Kuroda M; Iwaya K; Mukai K
Virchows Arch; 2002 Oct; 441(4):400-5. PubMed ID: 12404066
[TBL] [Abstract][Full Text] [Related]
13. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease.
Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS
Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease.
Sun X; Chang KC; Abruzzo LV; Lai R; Younes A; Jones D
Hum Pathol; 2003 Sep; 34(9):835-40. PubMed ID: 14562277
[TBL] [Abstract][Full Text] [Related]
15. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells.
Pauwels P; Dal Cin P; Vlasveld LT; Aleva RM; van Erp WF; Jones D
Am J Surg Pathol; 2000 Jun; 24(6):882-8. PubMed ID: 10843293
[TBL] [Abstract][Full Text] [Related]
16. Follicular dendritic cell tumor: review of the entity.
Perez-Ordoñez B; Rosai J
Semin Diagn Pathol; 1998 May; 15(2):144-54. PubMed ID: 9606805
[TBL] [Abstract][Full Text] [Related]
17. Primary hyaline vascular Castleman disease of the kidney: case report and literature review.
Li Y; Zhao H; Su B; Yang C; Li S; Fu W
Diagn Pathol; 2019 Aug; 14(1):94. PubMed ID: 31439011
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic anomalies in hyaline vascular Castleman disease: report of two cases with reappraisal of histogenesis.
Chen WC; Jones D; Ho CL; Cheng CN; Tseng JY; Tsai HP; Chang KC
Cancer Genet Cytogenet; 2006 Jan; 164(2):110-7. PubMed ID: 16434312
[TBL] [Abstract][Full Text] [Related]
20. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized.
Chan JK; Fletcher CD; Nayler SJ; Cooper K
Cancer; 1997 Jan; 79(2):294-313. PubMed ID: 9010103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
